Effectivenss of an Siddha treatment approach in SARS-COV-2 and COVID-19 - A Randomized controlled trail (Unblinded) at Govt. Kipauk Medical College, Chennai-10

Government siddha medical college1 个研究点分布在 1 个国家目标入组 100 人开始时间: 2020年7月8日最近更新: 2020年5月8日

试验速览

阶段: 2 期
状态: 尚未招募
发起方
入组人数: 100
试验地点: 1
主要终点: Outcomes is mainly assessed by reduction in Clinical symptoms and Rt-PCR test Negative

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of the proposal of these Siddha trail medicines is to validate the therapeutic efficacy and safety profile to administer for the SARS-CoV-2 COVID-19 which has been more dreadful for the community and more challenging in treating the disease especially of severe respiratory illness which causes more severity. I entitled that this drug is very easy to collect and lesser economic in production.I concluded that this medicine will be a treasure for our Siddha system of medicine. It can be helpful in improving our Indian economy through this medicine, I hope this drug will be safe and promising drug for SARS-CoV2-COVID-19.

研究设计

研究类型: Interventional
分配方式: Not Applicable
盲法: Open Label

入排标准

年龄范围: 15.00 Year(s) 至 80.00 Year(s)（—）
性别: All

入选标准

•Rt-PCR positive patients, Asymptomatic patients, Fever, Dry cough, Sore throat, Difficulty in breathing.

排除标准

•Bronchogeniccarcinoma, Pulmonary TB, Pregnancy and lactating mothers, Status asthmatics.

结局指标

主要结局

Outcomes is mainly assessed by reduction in Clinical symptoms and Rt-PCR test Negative

时间窗: 3 Months

次要结局

Outcomes is mainly assessed by reduction in Clinical symptoms and Rt-PCR test Negative(The outcome is assessed by patients recovery progress with faster reductions in clinical symptoms and Rt-PCR test negative,also to avoid the mortality rate by administering Allopathy and Siddha medicines for the easy recovery and saftety measures in the treatment for SARS-CoV-2 and COVID-19.)

研究者

发起方

Government siddha medical college

申办方类型

Government medical college

研究点 (1)

Loading locations...

相似试验

尚未招募

2 期

SARS-COV-2 and COVID-19 - A Randomized controlled trail (unblinded)

CTRI/2020/08/027033Government siddha medical college

已完成

2 期

Clinical evaluation of siddha drug brahmi nei(internal) and mahavilwathy thylam (external) for attention deficit hyperactivity disorder in childre

CTRI/2021/08/035465ational institute of siddha20

尚未招募

3 期

Evaluating therapeutic efficacy of VASANTHAKUSUMAKARAM MATHIRAI for PITHA NEER CHURUKU(Urinary Tract Infection)

CTRI/2023/03/050696ational Institute Of Siddha

尚未招募

3 期

Preclinical and clinical study of siddha drugs Raja elathy choornam(internal) and Nathaichoori ennai(external) in the treatment of shoulder pain (Kumbavatham) with and without varmam.

CTRI/2017/05/008593Ayothidoss pandithar hospital40

尚未招募

不适用

Treatment for Knee joint ligament injury through Siddha system of medicine.

CTRI/2018/09/015837Dr Monika M